Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Triclose
1. 62973-76-6
2. Yp2y0drx4s
3. (e)-2-amino-4-(2-(1-methyl-5-nitroimidazol-2-yl)vinyl)pyrimidine
4. Azanidazol
5. Nitromidine
6. 4-[(e)-2-(1-methyl-5-nitroimidazol-2-yl)ethenyl]pyrimidin-2-amine
7. Azanidazolum
8. Triclose
9. 2-pyrimidinamine, 4-(2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl)-, (e)-
10. Azanidazol [inn-spanish]
11. Azanidazolum [inn-latin]
12. Unii-yp2y0drx4s
13. Brn 4495385
14. 4-((e)-2-(1-methyl-5-nitro-1h-imidazol-2-yl)-ethenyl)-2-pyrimidinamine
15. Azanidazole [usan:inn:ban]
16. Azanidazole [mi]
17. Azanidazole [inn]
18. Azanidazole (usan/inn)
19. Azanidazole [usan]
20. 4-((e)-2-(1-methyl-5-nitro-1h-imidazol-2-yl)-aethenyl)-2-pyrimidinamin
21. Pyrimidine, 2-amino-4-((e)-2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl)-
22. 4-((e)-2-(1-methyl-5-nitro-1h-imidazol-2-yl)-aethenyl)-2-pyrimidinamin [german]
23. Azanidazole [mart.]
24. Azanidazole [who-dd]
25. Schembl668406
26. Chembl134920
27. Schembl20856187
28. Dtxsid40212180
29. Chebi:135001
30. 4-(2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl)-2-pyrimidinamine (e)
31. Db13350
32. D03028
33. Q523771
34. 4-[2-(1-methyl-5-nitro-1h-imidazol-2-yl)ethenyl]-2-pyrimidinamine
35. (e)-4-(2-(1-methyl-5-nitro-1h-imidazol-2-yl)vinyl)pyrimidin-2-amine
| Molecular Weight | 246.23 g/mol |
|---|---|
| Molecular Formula | C10H10N6O2 |
| XLogP3 | -0.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 246.08652358 g/mol |
| Monoisotopic Mass | 246.08652358 g/mol |
| Topological Polar Surface Area | 115 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 331 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
G - Genito urinary system and sex hormones
G01 - Gynecological antiinfectives and antiseptics
G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AF - Imidazole derivatives
G01AF13 - Azanidazole
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AB - Nitroimidazole derivatives
P01AB04 - Azanidazole
Global Sales Information
ABOUT THIS PAGE
A Azanidazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azanidazole, including repackagers and relabelers. The FDA regulates Azanidazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azanidazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azanidazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azanidazole supplier is an individual or a company that provides Azanidazole active pharmaceutical ingredient (API) or Azanidazole finished formulations upon request. The Azanidazole suppliers may include Azanidazole API manufacturers, exporters, distributors and traders.
click here to find a list of Azanidazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Azanidazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azanidazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azanidazole GMP manufacturer or Azanidazole GMP API supplier for your needs.
A Azanidazole CoA (Certificate of Analysis) is a formal document that attests to Azanidazole's compliance with Azanidazole specifications and serves as a tool for batch-level quality control.
Azanidazole CoA mostly includes findings from lab analyses of a specific batch. For each Azanidazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azanidazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Azanidazole EP), Azanidazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azanidazole USP).
LOOKING FOR A SUPPLIER?
